FDA unveils trio of new draft guidances to help cell and gene therapy developers

The FDA’s bi­o­log­ics cen­ter on Wednes­day of­fered its lat­est rec­om­men­da­tions to help stream­line the de­vel­op­ment of nov­el cell and gene ther­a­pies for small pa­tient pop­u­la­tions …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.